Carly Skowron – Trademark Portfolio
Entity Type: 01
Carly Skowron holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include THE LYMPH DOCTOR. The owner is based in Orem, UT.
893 S 830 E St.
Orem, UT 84097
Showing of trademarks Trademarks
Trademark Classifications
Carly Skowron's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Carly Skowron have?
Carly Skowron has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.
What trademark classes does Carly Skowron file in?
Carly Skowron files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Carly Skowron's most well-known trademarks?
Carly Skowron's registered trademark portfolio includes well-known marks such as THE LYMPH DOCTOR. These are among 1 currently registered trademark in the portfolio.
What is Carly Skowron's trademark registration success rate?
Carly Skowron has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.